Exabis Library:

Welcome to the e-CCO Library!

Search by:

All Congress AbstractsCongress SlidesTools & SkillsVideos & Podcasts

Year: Category:

DOP01 Exclusive enteral nutrition for the treatment of adult Crohn’s disease

Year: 2020

Source: ECCO'20 Vienna

Authors: D. Shukla, L. Purcell, M. Palmer, L. Pillay

Created: Thursday, 30 January 2020, 10:12 AM

Last Modified: Tuesday, 4 August 2020, 1:21 PM by Dauren Ramankulov

DOP010: Activating PIK3CD mutations cause severe intestinal lymphonodular hyperplasia and an IBD-like phenotype

Year: 2018

Source: ECCO '18 Vienna

Authors:

S. Farachi¹, L. Werner², L. Konnikova³, F. Rea¹, I. Vardi⁴, E. Romeo¹, O. Barel⁴, P. De Angelis¹, L. Dall’Oglio¹, G. Rechavi⁴, S. Snapper³, R. Somech², B. Weiss⁵, C. Cancrini¹, D. Shouval²*

Created: Thursday, 21 February 2019, 9:14 AM

DOP010: ECCO topical review on transitional care in inflammatory bowel disease

Year: 2017

Source: ECCO '17 Barcelona

Authors:

van Rheenen P. ECCO Transition Topical Review Consensus Group

Created: Wednesday, 20 February 2019, 10:36 AM

DOP010: ECCO Topical Review on Transitional Care in Inflammatory Bowel Disease

Year: 2017

Source: ECCO'17 Barcelona

Authors: van Rheenen P.

Paediatric, Transfer, Transition

Files: 1

DOP010: Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from a Central European nationwide cohort

Year: 2016

Source: ECCO '16 Amsterdam

Authors:

A. Bálint*¹, K. Farkas¹, M. Rutka¹, Z. Végh², Z. Kürti³, J. Banai⁴, L. Bene⁵, B. Gasztonyi⁶, T. Kristóf⁷, L. Lakatos⁸, P. Miheller⁹, K. Palatka¹⁰, A. Patai¹¹, A. Salamon¹², T. Szamosi⁴, Z. Szepes¹, G.T. Tóth¹³, A. Vincze¹⁴, R. Bor¹, A. Milassin¹, F. Nagy¹, M. Kolar^{15, 16}, M. Bortlik^{15, 17}, D. Duricova^{15, 18}, V. Hruba¹⁵, M. Lukas¹⁵, K. Mitrova^{15, 19}, K. Malickova²⁰, M. Lukas^{15, 20}, P.L. Lakatos², T. Molnár¹

Created: Friday, 22 February 2019, 9:49 AM

DOP010: Frequency and Characteristics of Infusion Reactions during Biosimilar Infliximab Treatment in Inflammatory Bowel Diseases: results from Central European nationwide cohort

Year: 2016

Source: ECCO'16 DOP

Authors: Balint A.

anti-TNF agents, biosimilars, Ulcerative Colitis, Crohn's Disease, trough levels

Files: 1

DOP011: Early immunomodulator exposure and the long-term outcome of Crohn’s disease: target for changing the natural history

Year: 2016

Source: ECCO '16 Amsterdam

Authors:

S. Jeuring*^{1, 2}, D. Wintjens¹, A. Wesselius³, T. Van den Heuvel^{1, 2},  M. Zeegers^{3, 4}, W. Hameeteman¹, M. Romberg-Camps⁵, L. Oostenbrug⁶, A. Masclee^{1, 2}, D. Jonkers^{1, 2}, M. Pierik^{1, 2}

Created: Friday, 22 February 2019, 9:49 AM

DOP011: Early immunomodulator exposure and the long-term outcome of Crohn’s disease: target for changing the natural history?

Year: 2016

Source: ECCO'16 DOP

Authors: Jeuring S.

Thiopruines (AZA / MP), Crohn's Disease

Files: 1

DOP011: Genotype–phenotype association analysis of inflammatory bowel disease in 6395 East Asian subjects: results from the international IBD Genetics Consortium

Year: 2018

Source: ECCO '18 Vienna

Authors:

S. Abedian¹*, S.H. Wong², S. Van Sommeren³, A. Takahashi⁴, J.H. Cheon⁵, W.H. Kim⁵, K. Yamazaki⁶, S.-K. Yang⁷, M. Kubo⁶, R.K. Weersma³, B.Z. Alizadeh¹, S.C. Ng²

Created: Thursday, 21 February 2019, 9:14 AM

DOP011: Genotype-Phenotype association analysis of Inflammatory Bowel Disease in 6,395 East Asian subjects: Results from the international IBD Genetics Consortium

Year: 2018

Source: ECCO'18 Vienna

Authors: Abedian Shifteh

Created: Tuesday, 8 May 2018, 11:36 AM

Files: 1

DOP011: Risk of opportunistic infection in healthcare personnel with Inflammatory Bowel Disease: A case-control study of the GETAID

Year: 2017

Source: ECCO'17 Barcelona

Authors: Amiot A.

Clostridium difficile, CMV, EBV, Morbidity, Tuberculosis

Files: 1

DOP011: Risk of opportunistic infection in healthcare personnel with inflammatory bowel disease: a case-control study of the GETAID

Year: 2017

Source: ECCO '17 Barcelona

Authors:

Gagniere C.^*1, Bourrier A.², Seksik P.², Gornet J.-M.³, Dewit O.⁴, Nancey S.⁵, Altwegg R.⁶, Abitbol V.⁷, Laharie D.⁸, Reenaers C.⁹, Buisson A.¹⁰, Nachury M.¹¹, Viennot S.¹², Vuitton L.¹³, Stefanescu C.¹⁴, Marteau P.¹⁵, Bouguen G.¹⁶, Cosnes J.², Amiot A.¹

Created: Wednesday, 20 February 2019, 10:36 AM

DOP012: Disease demarcation in ulcerative colitis is associated with different patterns of gene expression

Year: 2018

Source: ECCO '18 Vienna

Authors:

M. Suarez-Farinas¹, R. Huang¹, R. Kosoy¹, A. Irizar¹, B. Losic¹, G. Wei¹, L. Peters¹, W.-m. Song¹, A. Di Narzo¹, W. Wang¹, J. Perrigoue², A. Castillo³, J. Rogers³, A. Atreja³, A. Hurley¹, M. Mahajan¹, B. Zhang¹, A. Stojmirovic², M. Curran², R. Dobrin²,⁴, M. Dubinsky³, K. Hao¹, J. Zhu¹, E. Schadt¹, S. Plevy², J. Friedman², C. Brodmerkel², B. Sands³, A. Kasarskis¹, R. Ungaro³, C. Argmann¹*, J.-F. Colombel³

Created: Thursday, 21 February 2019, 9:14 AM

DOP012: Disease demarcation in Ulcerative Colitis is associated with different patterns of gene expression

Year: 2018

Source: ECCO'18 Vienna

Authors: Argmann Carmen

Created: Tuesday, 8 May 2018, 11:36 AM

Files: 1

DOP012: Do ulcerative colitis patients treated with corticosteroids at diagnosis really have a more aggressive disease course?

Year: 2016

Source: ECCO '16 Amsterdam

Authors:

L. Bertani*¹, N. de Bortoli¹, G. Bodini², G. Mumolo³, L. Ceccarelli⁴, M. C. Plaz Torres², G. Laino¹, M. Bellini³, A. Ricchiuti³, V. Savarino², S. Marchi¹, F. Costa³